Press Room

Share

American Cancer Society Expert Testifies About the Problem of Drug Shortages for Cancer Patients and Survivors

September 26, 2011

WASHINGTON, D.C. - September 26, 2011 - Dr. Len Lichtenfeld, the American Cancer Society's deputy chief medical officer, testified today at a hearing of the U.S. Food and Drug Administration about the drug shortage crisis and its impact on people with cancer. 

FOR MORE INFO, CONTACT:
Steven Weiss or Alissa Havens
Email: steve.weiss@cancer.org or alissa.havens@cancer.org
Phone: 202-661-5711 or 202-661-5772  

More Press Releases AboutAccess to Health Care

Related Press Releases

May 12, 2025

Colorado Cancer Advocates Ask Rep. Gabe Evans to Protect Medicaid by Opposing Cuts

Today, Colorado advocates with the American Cancer Society Cancer Action Network (ACS CAN) delivered over 200 postcards signed by constituents to Rep. Gabe Evans’ district office in Northglenn, urging him to protect Medicaid by opposing any cuts to the program. The postcards highlighted how looming cuts to Medicaid would harm millions of Coloradans, including working families, cancer patients and survivors, pregnant women, people with disabilities, seniors, veterans and children.

Read More
May 12, 2025

House Energy and Commerce Committee’s Plan to Cut Medicaid Will Lead to More Suffering and Death from Cancer

The U.S. House Energy and Commerce Committee released a budget proposal late last night that would drastically slash funding for Medicaid by $715 billion.

Read more
May 8, 2025

New York State Budget Fails to Address Paid Leave

This week, New York state leaders released details on the state budget for FY 2025-26 and patient advocates are responding with disappointment over the failure to produce solutions to improve New Yorkers’ access to paid leave and, with it, their financial mobility. The same advocates visited Albany last month for the American Cancer Society Cancer Action Network’s (ACS CAN) annual Cancer Action Day to promote the importance of Senate Bill 172/Assembly Bill 84, the proposal to improve New Yorkers’ access to time off during treatment which now has 73 Assembly co-sponsors and passed the Senate in March.   

Read more